Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AAL vs MRNA✓SelectedUSD · MRNAAAL vs MRNA performance historyLatest closeAs of-2.42%11/17
Stock and ETF performance explorer

AAL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-60.9%
MRNA return
+840.0%
Excess return
-900.9%
Maximum drawdown
-75.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.4%-3.9%+1.5%-2.2%
7D-8.4%-17.6%+9.1%-7.6%
30D+8.8%-5.1%+13.9%+8.9%
3M-10.5%+220.8%-231.3%-18.0%
6M+5.0%+321.7%-316.7%-6.4%
YTD-15.7%+601.3%-617.0%-28.1%
1Y+4.7%+735.2%-730.5%-11.9%
3Y+5.1%+170.5%-165.4%-7.0%
5Y-34.9%-14.6%-20.3%-42.8%
All-60.9%+840.0%-900.9%-63.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling